Cargando…
Novel treatment options in depression and psychosis
In spite of tremendous development in central nervous system research, current treatment is suboptimal, especially in severe mental disorders. In medicine, there are two main methods of improving the health care provided: seeking new treatment procedures and perfecting (optimizing) the existing ones...
Autores principales: | Ceskova, Eva, Silhan, Petr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856289/ https://www.ncbi.nlm.nih.gov/pubmed/29559781 http://dx.doi.org/10.2147/NDT.S157475 |
Ejemplares similares
-
From Personalized Medicine to Precision Psychiatry?
por: Češková, Eva, et al.
Publicado: (2021) -
Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis
por: Hýža, Martin, et al.
Publicado: (2021) -
Selected neuroendocrine factors as potential molecular biomarkers of early non-affective psychosis course in relation to treatment outcome: A pilot study
por: Obdržálková, Marie, et al.
Publicado: (2023) -
Combination of antidepressants and antipsychotics as a novel treatment option for psychosis in Alzheimer's disease
por: Fan, Peihao, et al.
Publicado: (2023) -
Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective
por: Přikryl, Radovan, et al.
Publicado: (2012)